Crohn's disease and cancer risk. Incidence/prevalence, clinical characteristics, and potential prevention strategies;Morbus Crohn und malignomrisiko. Häufigkeit, klinische charakteristika und mögliche präventionsstrategien

Medizinische Klinik

Volumn 102, Issue 9, 2007, Pages 727-733

  Allgayer, Hubert ^a,b   Holtmeier, Wolfgang ^c   Dietrich, Christoph F ^b,d  

^a Rehaklinik Ob der Tauber   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d CARITAS KRANKENHAUS   (Germany)

Author keywords

Cancer risk; Colorectal cancer; Crohn's disease; Prevention; Small bowel cancer

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE;

CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CLINICAL PRACTICE; COLORECTAL CANCER; CONFIDENCE INTERVAL; CROHN DISEASE; DISEASE ACTIVITY; HUMAN; MORTALITY; PRACTICE GUIDELINE; PREVALENCE; REVIEW; RISK FACTOR; SCLEROSING CHOLANGITIS; SMALL INTESTINE CANCER; TUMOR LOCALIZATION; ULCERATIVE COLITIS;

ADULT; COHORT STUDIES; COLORECTAL NEOPLASMS; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HUMANS; INCIDENCE; INTESTINAL NEOPLASMS; INTESTINE, SMALL; MALE; PROSPECTIVE STUDIES; RISK FACTORS; STATISTICS AS TOPIC; SURVIVAL ANALYSIS;

EID: 34648830191     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-007-1091-7     Document Type: Review

References (68)

1. Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol 1996;91:44-8.
2. Munkholm P. The incidence and prevalence of colorectal cancer in inflammatory bowel disease [Review Article]. Aliment Pharmacol Ther 2003;18:1-5.
3. Becker N, Wahrendorf J. Krebsatlas der Bundesrepublik Deutschland, 3. Aufl. Berlin-Heidelberg-New York: Springer, 1990.
4. Schmiegel W, Pox C, Kroesen A. Karzinomprophylaxe. Z Gastroenterol 2004;42:1014-8.
5. Itzkowitz S, Yio X. Inflammation and cancer. IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7-17.
6. Warren S, Sommers SC. Cicatrizing enteritis as a pathological entity. Am J Pathol 1948;24:475-501.
7. Ginzberg L, Schneider KM. Carcinoma of the jejunum occurring in a case of regional enteritis. Surgery 1956;39:347-51.
8. Bernstein D, Rogers A. Malignancy in Crohn's disease. Am J Gastroenterol 1996;91:434-44.
9. Chaikhouni A, Regueyra FI, Stevens JR. Adenocarcinoma in perineal fistulas of Crohn's disease. Dis Colon Rectum 1981;24:639-43.
10. Connell WR, Sheffield JP, Kamm MA, et al. Lower gastrointestinal malignancy in Crohn's disease. Gut 1994;35:347-52.
11. Ekbom A, Helmik C, Zack M, et al. Increased risk of large bowel cancer in Crohn's disease with colonic involvement. Lancet 1990;336:357-9.
12. Fireman Z, Grossman A, Lilos P, et al. Intestinal cancer in patients with Crohn's disease. A population study in central Israel. Scand J Gastroenterol 1989;24:346-50.
13. Gillen CD, Andrews HA, Prior P, et al. Crohn's disease and colorectal cancer. Gut 1994;35:651-5.
14. Gillen CD, Wamsley RS, Prior P, et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994;35:1590-2.
15. Glotzer DJ. The risk of cancer in Crohn's disease. Gastroenterology 1985;89:438-41.
16. Greenstein AJ. Cancer in inflammatory bowel disease. Mt Sinai J Med 2000;67:227-40.
17. Greenstein AJ, Sachar D, Pucillo A, et al. Cancer in Crohn's disease after divisionary surgery. A report of seven carcinomas occuring in excluded bowel. Am J Surg 1978;135:86-90.
18. Greenstein AJ, Sachar D, Smith H, et al. A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 1981;48:2742-5.
19. Gyde SN, Prior P, Macartney JC, et al. Malignancy in Crohn's disease. Gut 1980;21:1024-9.
20. Hamilton SR. Colorectal carcinoma in patients with Crohn's disease. Gastroenterology 1985;89:398-407.
21. Hawker PC, Gyde SN, Thompson H, et al. Adenocarcinoma of the small intestine complicating Crohn's disease. Gut 1982;23:188-93.
22. Hoffman JP, Taft DA, Wheelis RF, et al. Adenocarcinoma in regional enteritis of the small intestine. Arch Surg 1977;12:606-11.
23. Korelitz BI. Carcinoma of the intestinal tract in Crohn's disease: results of a survey conducted by the National Foundation for Ileits and Colitis. Am J Gastroenterol 1983;78:44-6.
24. Kvist N, Jacobsen O, Norgaard P, et al. Malignancy in Crohn's disease. Scand J Gastroenterol 1986;21:82-6.
25. Kyle J, Ewen SW. Two types of colorectal carcinoma in Crohn's disease. Ann R Coll Surg Engl 1992;74:387-90.
26. Mayer R, Wong WD, Rothenberger DA, et al. Colorectal cancer in inflammatory bowel disease: a continuing problem. Dis Colon Rectum 1999;42:343-7.
27. Munkholm P, Langholz E, Davidsen M, et al. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993;105:1716-23.
28. Nikias G, Eisner T, Katz S, et al. Crohn's disease and colorectal carcinoma: rectal cancer complicating longstanding active perianal disease. Am J Gastroenterol 1995;90:216-9.
29. Persson PG, Karlen P, Bernell O, et al. Crohn's disease and cancer: a population-based cohort study. Gastroenterology 1994;107:1675-9.
30. Ribeiro MB, Greenstein AJ, Heimann TM, et al. Adenocarcinoma of the small intestine in Crohn's disease. Surg Gynecol Obstet 1991;173:343-9.
31. Rubio CA, Befrits R. Colorectal adenocarcinoma in Crohn's disease: a retrospective histologic study. Dis Colon Rectum 1997;40:1072-8.
32. Savoca PE, Ballantyne GH, Cahow CE. Gastrointestinal malignacies in Crohn's disease. A 20-year experience. Dis Colon Rectum 1990;33:7-11.
33. Palli D, Masala G, Sera F, et al. Colorectal cancer risk in patietns affected with Crohn's disease. Am J Gastroenterol 2006;101:1400-1.
34. Palma P, Post S. Malignitätsrisiko bei chronisch-entzündlichen Darmerkrankungen. Onkologe 2004;10:203-12.
35. Kersting S, Bruewer M, Laukoetter MG, et al. Intestinal cancer in patients with Crohn's disease. Int J Colorectal Dis 2006;22:411-7.
36. Winkler R, Wittmer A, Heusermann U. Das Karzinom bei M. Crohn. Z Gastroenterol 2002;40:569-76.
37. Eaden J. Colorectal carcinoma and inflammatory bowel disease [Review Article]. Alim Pharmacol Ther 2004;20:24-30.
38. Sjödahl RI, Myrelid P, Söderjholm JD. Anal and rectal cancer in Crohn's disease. Colorectal Dis 2003;5:490-5.
39. Freeman HJ. Colorectal cancer complicating Crohn's disease. Can J Gastroenterol 2001;15:231-6.
40. Solem CA, Harmsen WS, Zinsmeister AR, et al. Small intestinal adenocarcinoma in Crohn's disease: a case-control study. Inflamm Bowel Dis 2004;10:32-5.
41. Maykel JA, Hagerman G, Mellgren AF, et al. Crohn's disease: the incidence of dysplasia and adenocarcinoma in surgical patients. Dis Colon Rectum 2006;49:950-7.
42. Michaelis J. Epidemiologie - Wissenschaft für die Praxis. Dtsch Ärztebl 1990;87:C1741-6.
43. Rothman KJ. Epidemiology - an introduction. New York: Oxford University Press, 2002.
44. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006;23:1097-104.
45. Jess T, Gamborg M, Matzen P, et al. Increaased risk of intestinal cancer in Crohn's disease: a meta-analysis of popuation-based cohort studies. Am J Gastroenterol 2005;100:2724-9.
46. Jess T, Winther KV, Munkholm P, et al. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 2004;19:287-93.
47. Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology 2006;130:1039-46.
48. Jess T, Loftus EV, Velayos FS, et al. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen County, Denmark, and Olmsted County, Minnesota. Am J Gastroenterol 2007;102:829-36.
49. Jess T, Loftus EV, Harmsen WS, et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long-term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 2006;55:1248-54.
50. Choi PM, Zelig MP, Nugent FW, et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993;105:418-24.
51. Connell WR, Kamm MA, Dickson M, et al. Long-term neoplastic risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994;343:1249-52.
52. Ribeiro MB, Greenstein AJ, Sachar D, et al. Colorectal adenocarcinoma in Crohn's disease. Ann Surg 1996;223:186-93.
53. Collins PD, Mpofu C, Watson AJ, et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006;2:CD000279.pub3.
54. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006;130:1030-8.
55. Korelitz BI. Considerations of surveillance, dysplasia, and carcinoma of the colon in the management of ulcerative colitis and Crohn's disease. Med Clin North Am 1990;74:189-99.
56. Stahl TJ, Schoetz DJ Jr, Roberts PL, et al. Crohn's disease and carcinoma: increasing justification for surveillance? Dis Colon Rectum 1992;35:850-6.
57. Wagner JL, Tunis S, Brown M, et al. Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young GP, Rozen P, Levin B, eds. Prevention and early detection of colorectal cancer. Philadelphia: Saunders, 1996:321-8.
58. Allgayer H, Kruis W. Aminosalicylates: potential antineoplastic actions in colon cancer prevention. Scand J Gastroenterol 2002;37:125-31.
59. Matula S, Croog V, Itzkowitz S, et al. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of mercaptopurine. Clin Gastroenterol Hepatol 2005;3:1015-21.
60. Allgayer H, Kruis W. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of mercaptopurine [Letter]. Clin Gastroenterol Hepatol 2006;4:521-2.
61. Weedon DD, Shorter RG, Ilstrup DM, et al. Crohn's disease and cancer. N Engl J Med 1973;289:1099-103.
62. Gollop JH, Philips SF, Melton LJ, et al. Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut 1988:29:49-56.
63. Mellemkjaer L, Johansen C, Gridley G, et al. Crohn's disease and cancer risk (Denmark). Cancer Causes Control 2000;11:145-50.
64. Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 205;111:314-21.
65. Siegel CA, Sands BE. Risk factors for colorectal cancer in Crohn's colitis: a case-control study. Inflamm Bowel Dis 2006;12:491-6.
66. Sjöqvist U, Befrits R, Söderlund S, et al. Colorectal cancer in colonic Crohn's disease - high frequency of DNA-aneuploidy. Anticancer Res 2005;25:4393-7.
67. Hirche TO, Russler J, Schroder O, et al. The value of routinely performed ultrasonography in patients with Crohn disease. Scand J Gastroenterol 2002;37:1178-83.
68. Hirche TO, Russler J, Braden B, et al. Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease. Int J Colorectal Dis 2004;19:586-94.